A month has gone by since the last earnings report for Momenta Pharmaceuticals, Inc. (MNTA - Free Report) . Shares have lost about 9.6% in that time frame, underperforming the market. Will the recent negative trend …
ZACKS1mon
Earnings
Hedge fund activity in Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) At the end of the third quarter, a total of 17 of the hedge funds tracked by Insider Monkey held long positions in this stock, a change of -11% from the …
However, it is difficult to see why the situation has changed so radically to justify a 20% loss in the MNTA stock price. The other companies involved in this dispute, Sanofi-Aventis and Teva did not experience such radical …
Today's Most Active Call & Put Options of the S&P 500 » Momenta Pharmaceuticals Inc (MNTA) saw options trading volume of 7,082 contracts, representing approximately 708,200 underlying shares or approximately …
Momenta Pharmaceuticals Inc. (MNTA) is a Massachusetts based biotechnology company that could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but …
Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA), announced today that is has changed the time ... Register …
Finance
This may be only the beginning of bearish brokerage attention for Cidara Therapeutics Inc, since five out of six analysts call the stock a "strong buy." MNTA is also selling off today, down 15.3% at $16.10 and SSR, after …
Stock
Momenta Pharma stock analysis involves checking at least a few of the important things like: Top line: The word topline comes from the fact that the first line of an income statement refers to sales numbers. If you check …
Hedge funds and investors now own approximately 85% of MNTA’s stock. Momenta reported its financial results for the nine months ended September 30, 2016 early last month. For the nine-month period, the company …
Stock market analysts and brokers have recently amended their target prices on shares of Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA). According to the latest research reports released, 2 analysts have …